Researchers seeking a less invasive, more objective way to classify posttraumatic stress disorder (PTSD) have become interested in speech-based biomarkers, building on previous work associating vocal changes with mood disorders. The current gold standard method for diagnosing PTSD, a structured interview called the Clinician-Administered PTSD Scale (CAPS), is lengthy, challenging for patients, and subject to the clinician’s interpretation.
Abbasi J. Using Speech Markers to Diagnose PTSD. JAMA. 2019;321(22):2155. doi:10.1001/jama.2019.7550
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: